KalVista Pharmaceuticals Inc (KALV)
9.325
+0.36
(+4.07%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Total Assets (Quarterly): 200.20M for July 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 200.20M |
| April 30, 2024 | 235.40M |
| January 31, 2024 | 113.97M |
| October 31, 2023 | 138.74M |
| July 31, 2023 | 160.33M |
| April 30, 2023 | 183.20M |
| January 31, 2023 | 203.47M |
| October 31, 2022 | 162.84M |
| July 31, 2022 | 182.32M |
| April 30, 2022 | 203.88M |
| January 31, 2022 | 225.05M |
| October 31, 2021 | 243.81M |
| July 31, 2021 | 259.13M |
| April 30, 2021 | 272.01M |
| January 31, 2021 | 66.21M |
| October 31, 2020 | 75.45M |
| July 31, 2020 | 83.90M |
| April 30, 2020 | 92.53M |
| January 31, 2020 | 102.94M |
| October 31, 2019 | 112.06M |
| July 31, 2019 | 119.88M |
| Date | Value |
|---|---|
| April 30, 2019 | 118.13M |
| January 31, 2019 | 126.52M |
| October 31, 2018 | 132.56M |
| July 31, 2018 | 57.62M |
| April 30, 2018 | 61.39M |
| January 31, 2018 | 66.66M |
| October 31, 2017 | 34.74M |
| July 31, 2017 | 30.78M |
| April 30, 2017 | 34.34M |
| January 31, 2017 | 38.05M |
| September 30, 2016 | 35.86M |
| June 30, 2016 | 38.01M |
| March 31, 2016 | 49.68M |
| December 31, 2015 | 56.79M |
| September 30, 2015 | 62.08M |
| June 30, 2015 | 67.60M |
| March 31, 2015 | 7.712M |
| December 31, 2014 | 6.644M |
| September 30, 2014 | 10.86M |
| December 31, 2013 | 10.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
66.21M
Minimum
Jan 2021
272.01M
Maximum
Apr 2021
168.70M
Average
182.32M
Median
Jul 2022
Total Assets (Quarterly) Benchmarks
| Nuwellis Inc | 6.728M |
| Perspective Therapeutics Inc | 391.15M |
| Electromed Inc | 48.92M |
| Xtant Medical Holdings Inc | 98.88M |
| Myomo Inc | 16.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.40M |
| Shareholders Equity (Quarterly) | 172.80M |